Accelerated partial breast irradiation in the elderly: 5-year results of high-dose rate multi-catheter brachytherapy
- PMID: 24886680
- PMCID: PMC4045692
- DOI: 10.1186/1748-717X-9-115
Accelerated partial breast irradiation in the elderly: 5-year results of high-dose rate multi-catheter brachytherapy
Abstract
Objective: To evaluate clinical outcome after accelerated partial breast irradiation (APBI) in the elderly after high-dose-rate interstitial multi-catheter brachytherapy (HIBT).
Methods and materials: Between 2005 and 2013, 70 patients underwent APBI using HIBT. Catheter implant was performed intra or post-operatively (referred patients) after lumpectomy and axillary sentinel lymph node dissection. Once the pathological results confirmed the indication of APBI, planification CT-scan was performed to deliver 34 Gy/10f/5d or 32 Gy/8f/4d. Dose-volume adaptation was manually achieved (graphical optimization). Dosimetric results and clinical outcome were retrospectively analyzed. Physician cosmetic evaluation was reported.
Results: With a median follow-up of 60.9 months [4.6 - 90.1], median age was 80.7 years [62 - 93.1]. Regarding APBI ASTRO criteria, 61.4%, 18.6% and 20% were classified as suitable, cautionary and non-suitable respectively. Axillary sentinel lymph node dissection was performed in 94.3%; 8 pts (11.5%) presented an axillary involvement. A median dose of 34 Gy [32 - 35] in 8 to 10 fractions was delivered. Median CTV was 75.2 cc [16.9 - 210], median D90 EQD2 was 43.3 Gy [35 - 72.6] and median DHI was 0.54 [0.19 - 0.74]. One patient experienced ipsilateral recurrence (5-year local free recurrence rate: 97.6%. Five-year specific and overall survival rates were 97.9% and 93.2% respectively. Thirty-four patients (48%) presented 47 late complications classified grade 1 (80.8%) and grade 2 (19.2%) with no grade ≥ 3. Cosmetic results were considered excellent/good for 67 pts (95.7%).
Conclusion: APBI using HIBT and respecting strict rules of implantation and planification, represents a smart alternative between no post-operative irradiation and whole breast irradiation delivered over 6 consecutive weeks.
Figures
Similar articles
-
Five-year oncological outcome after a single fraction of accelerated partial breast irradiation in the elderly.Radiat Oncol. 2019 Dec 21;14(1):234. doi: 10.1186/s13014-019-1448-0. Radiat Oncol. 2019. PMID: 31864391 Free PMC article.
-
Late side-effects and cosmetic results of accelerated partial breast irradiation with interstitial brachytherapy versus whole-breast irradiation after breast-conserving surgery for low-risk invasive and in-situ carcinoma of the female breast: 5-year results of a randomised, controlled, phase 3 trial.Lancet Oncol. 2017 Feb;18(2):259-268. doi: 10.1016/S1470-2045(17)30011-6. Epub 2017 Jan 14. Lancet Oncol. 2017. PMID: 28094198 Clinical Trial.
-
Single fraction of accelerated partial breast irradiation in the elderly: early clinical outcome.Radiat Oncol. 2018 Sep 12;13(1):174. doi: 10.1186/s13014-018-1119-6. Radiat Oncol. 2018. PMID: 30208914 Free PMC article. Clinical Trial.
-
The MammoSite balloon brachytherapy catheter for accelerated partial breast irradiation.Semin Radiat Oncol. 2005 Apr;15(2):100-7. doi: 10.1016/j.semradonc.2004.10.006. Semin Radiat Oncol. 2005. PMID: 15809935 Review.
-
Multi-catheter interstitial accelerated partial breast irradiation - tips and tricks for a good insertion.J Contemp Brachytherapy. 2014 Mar;6(1):85-90. doi: 10.5114/jcb.2014.40767. Epub 2014 Feb 19. J Contemp Brachytherapy. 2014. PMID: 24790626 Free PMC article. Review.
Cited by
-
A systematic review on the techniques, long-term outcomes, and complications of partial breast irradiation after breast-conserving surgery for early-stage breast cancer.Sci Rep. 2024 Sep 27;14(1):22283. doi: 10.1038/s41598-024-73627-x. Sci Rep. 2024. PMID: 39333210 Free PMC article.
-
Catheter-based delineation of lumpectomy cavity for accurate target definition in partial-breast irradiation with multicatheter interstitial brachytherapy.J Contemp Brachytherapy. 2019 Apr;11(2):108-115. doi: 10.5114/jcb.2019.84504. Epub 2019 Apr 29. J Contemp Brachytherapy. 2019. PMID: 31139218 Free PMC article.
-
Efficacy and safety of adjuvant therapies in older patients with breast cancer: a systematic review and meta-analysis of real-world data.Breast Cancer. 2024 Sep;31(5):739-753. doi: 10.1007/s12282-024-01622-1. Epub 2024 Aug 1. Breast Cancer. 2024. PMID: 39085679
-
The Role of Brachytherapy in the Treatment of Breast Cancer.Breast Care (Basel). 2018 Jul;13(3):157-161. doi: 10.1159/000489638. Epub 2018 May 29. Breast Care (Basel). 2018. PMID: 30069174 Free PMC article. Review.
-
Age Is Not a Limiting Factor in Interventional Radiotherapy (Brachytherapy) for Patients with Localized Cancer.Biomed Res Int. 2018 Jan 21;2018:2178469. doi: 10.1155/2018/2178469. eCollection 2018. Biomed Res Int. 2018. PMID: 29581964 Free PMC article. Review.
References
-
- Fisher B, Anderson S, Bryant J, Margolese RG, Deutsch M, Fisher ER, Jeong JH, Wolmark N. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med. 2002;347:1233–1241. doi: 10.1056/NEJMoa022152. - DOI - PubMed
-
- Clarke M, Collins R, Darby S, Davies C, Elphinstone P, Evans E, Godwin J, Gray R, Hicks C, James S, MacKinnon E, McGale P, McHugh T, Peto R, Taylor C, Wang Y. Early Breast Cancer Trialists' Collaborative Group (EBCTCG) Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet. 2005;366:2087–2106. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical